BioLife Solutions, Inc. Debt Securities, Available-for-sale, Unrealized Loss Position
BioLife Solutions, Inc. (BLFS) had Debt Securities, Available-for-sale, Unrealized Loss Position of $76.20 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition · last filed 2026-08-06
- 2026-06-30: Debt Securities, Available-for-sale, Unrealized Loss Position $76.20M.
- 2026-03-31: Debt Securities, Available-for-sale, Unrealized Loss Position $57.93M.
- 2025-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position $7.52M.
- 2025-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position $6.18M.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position |
|---|---|
| 2026-06-30 | $76.20M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $57.93M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $7.52M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $6.18M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $15.56M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $9.99M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $3.12M 10-K · filed 2026-02-26 |
| 2023-12-31 | $6.78M 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |